Translate Bio, Inc. (TBIO): Price and Financial Metrics

Translate Bio, Inc. (TBIO): $0.90

0.05 (-5.26%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add TBIO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#313 of 329

in industry

TBIO Price/Volume Stats

Current price $0.90 52-week high $15.46
Prev. close $0.95 52-week low $0.89
Day low $0.90 Volume 4,000
Day high $0.95 Avg. volume 451,265
50-day MA $2.03 Dividend yield N/A
200-day MA $4.62 Market Cap 1.60M

TBIO Stock Price Chart Interactive Chart >


Translate Bio, Inc. (TBIO) Company Bio


Translate Bio, Inc., a messenger RNA therapeutics company, engages in developing medicines to treat diseases caused by protein or gene dysfunction. It is developing MRT5005 that is in Phase I/II clinical trial for the treatment of cystic fibrosis; and MRT5201 for the treatment of ornithine transcarbamylase deficiency. It has strategic alliances with Sanofi Pasteur. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. was founded in 2011 and is based in Lexington, Massachusetts.


TBIO Latest News Stream


Event/Time News Detail
Loading, please wait...

TBIO Latest Social Stream


Loading social stream, please wait...

View Full TBIO Social Stream

TBIO Price Returns

1-mo -58.33%
3-mo -73.84%
6-mo -73.91%
1-year -87.50%
3-year -99.29%
5-year N/A
YTD -87.47%
2023 -66.75%
2022 -88.89%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!